AGP Executive Report
Last update: 7 hours agoAlzheimer’s Research: New trial results presented at a Boston conference were mixed: AriBio’s oral drug slowed decline by 31% in a prespecified group not taking other Alzheimer’s medicines, while an at-home light-and-sound device missed its main goal. Five-year lecanemab data suggested slower progression, but relied on comparisons with people outside the trial. Universities: International enrollment fell 9% at surveyed U.S. colleges this fall, with groups estimating a $2.4 billion economic hit. A Massachusetts federal judge also struck down a rule that would have imposed fixed time limits on international students’ stays. Urban Technology: Cambridge used aerial lidar to find that residential properties—not city land—accounted for the largest tree-canopy losses. The findings helped support a tree-removal permit and replacement requirement. Climate Resilience: Boston Children’s Museum is planning a $15 million flood-protection project after a 2018 storm surrounded the waterfront building with water.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.